Friday, June 24, 2022
HomeCancerProstate Cancer Incidence By Country

Prostate Cancer Incidence By Country

African Americans And Non

Prostate Cancer Statistics

Incidence

and several other researchers noted that African American men have among the highest incidence of PCa worldwide, are more likely to develop PCa at any age, and develop the disease earlier in life than men from all other racial and ethnic groups. Parkin et al. noted that it is difficult to compare incidence rates among men of different races or compare rates between various countries because of differences in detection pathways and data collection.

The overall incidence of PCa increased in the United States between 1988 and 1992, but starting in 2007, it decreased at a rate of 6.5% per year for all races combined . The increase and decline in PCa incidence mimicked the dramatic increase and decrease in screening during the same years. That trend appears to be consistent with data from other studies. illustrates race-specific age-adjusted incidence rates of PCa in the U.S. population. Since the peak in 1992, PCa incidence has been decreasing in the United States with an accelerated rate of decrease since 2012. Several previous studies have suggested that the decline in incidence has been associated with recommendations by the 2012 USPSTF against routine PSA testing . highlights the disparity between men over 50 years who received at least one PSA test and the same category of men who received their first PSA test between 1985 and 2005.

Mortality

Reprinted from .

Awareness and early detection in African Americans and NHWs

Prostate Cancer Incidence By Uk Country

Prostate cancer is the most common cancer in males in the UK, accounting for 27% of all new cancer cases in males .In females and males combined, prostate cancer is the 2nd most common cancer in the UK, accounting for 14% of all new cancer cases .

Prostate cancer incidence rates rate ) for males are significantly higher than the UK average in England and Wales and significantly lower than the UK average in Scotland and Northern Ireland.

For prostate cancer, there are few established risk factors therefore differences between countries largely reflect differences in diagnosis and data recording.

Prostate Cancer , Average Number of New Cases Per Year, Crude and European Age-Standardised Incidence Rates per 100,000 Population, UK, 2016-2018

Who Dies From This Cancer

Because we have screening for prostate cancer, most of the time it is caught before it spreads to other parts of the body. Men who have prostate cancer that is characterized as localized or regional are not as likely to die as men whose cancer is distant. In general prostate cancer has excellent survival rates, but death rates are higher in African American men, men who have advanced stage cancer, and men who are between the ages of 75 and 84. Prostate cancer is the fifth leading cause of cancer death in the United States. The death rate was 19.0 per 100,000 men per year based on 20142018, age-adjusted.

Death Rate per 100,000 Persons by Race/Ethnicity: Prostate Cancer

Males

Read Also: Can Prostate Cancer Cause Dizziness

Distribution Of Cases And Deaths By World Region And Cancer Types

There were an estimated 19.3 million new cases and 10 million cancer deaths worldwide in 2020 . Figure presents the distribution of all-cancer incidence and mortality according to world region for both sexes combined and separately for men and women. For both sexes combined, one-half of all cases and 58.3% of cancer deaths are estimated to occur in Asia in 2020 , where 59.5% of the global population resides . Europe accounts for 22.8% of the total cancer cases and 19.6% of the cancer deaths, although it represents 9.7% of the global population, followed by the Americas’ 20.9% of incidence and 14.2% of mortality worldwide. In contrast to other regions, the share of cancer deaths in Asia and Africa are higher than the share of incidence because of the different distribution of cancer types and higher case fatality rates in these regions.

CANCER SITENO. OF NEW CASESNO. OF NEW DEATHS
Female breast
Nonmelanoma of skina New cases exclude basal cell carcinoma, whereas deaths include all types of nonmelanoma skin cancer.1,198,073
All sites excluding nonmelanoma skin18,094,716
19,292,7899,958,133
  • a New cases exclude basal cell carcinoma, whereas deaths include all types of nonmelanoma skin cancer.

Figure 4

Future Burden Of Cancer In 2040

Prostate cancer incidence and mortality rates by ...

Worldwide, an estimated 28.4 million new cancer cases are projected to occur in 2040, a 47% increase from the corresponding 19.3 million cases in 2020, assuming that national rates estimated in 2020 remain constant . The relative magnitude of increase is most striking in low HDI countries and in medium HDI countries . In terms of the absolute burden, the high HDI countries are expected to experience the greatest increase in incidence, with 4.1 million new cases more in 2040 compared with 2020. This projection is solely due to the growth and aging of the population and may be further exacerbated by an increasing prevalence of risk factors in many parts of the world.

Figure 24

You May Like: Is There Any Cure For Prostate Cancer

Global Cancer Data By Country

Exploring which countries have the highest cancer rates

On this page you can find age-standardised rates for all cancers ordered by the countries with the 50 highest rates.

The age-standardised rate for all cancers for men and women combined was 197.9 per 100,000 in 2018. The rate was higher for men than women .

With the burden growing in almost every country, prevention of cancer is one of the most significant public health challenges of the 21st century. Around 40% of cancer cases could be prevented by reducing exposure to cancer risk factors including diet, nutrition and physical activity for more information see our Cancer Prevention Recommendations or read our blog.

Reducing the cancer burden requires concerted and integrated action from all sectors of society, including civil society, private sector, and health and other professions. You can read what policy actions different countries are taking to promote healthier diets in our NOURISHING framework and accompanying database.

Age-standardised rates are used in the tables. This is a summary measure of the rate of disease that a population would have if it had a standard age structure. Standardisation is necessary when comparing populations that differ with respect to age because age has a powerful influence on the risk of dying from cancer.

Who Gets This Cancer

Prostate cancer occurs only in men, and it is more common in older men than younger men. It is more likely to occur in men with a family history of prostate cancer and men of African American descent. The rate of new cases of prostate cancer was 111.3 per 100,000 men per year based on 20142018 cases, age-adjusted.

Rate of New Cases per 100,000 Persons by Race/Ethnicity: Prostate Cancer

Males

SEER 21 20142018, All Races, Males

Recommended Reading: Best Scan For Prostate Cancer

Prostate Cancer Incidence By Age

Prostate cancer incidence is strongly related to age, with the highest incidence rates being in older men. In the UK in 2016-2018, on average each year around a third of new cases were in males aged 75 and over.

Age-specific incidence rates rise steeply from around age 45-49, peak in the 75-79 age group before dropping slightly and remaining stable in the oldest age groups.The highest rates are in in the 75 to 79 age group.

Prostate cancer , Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Male Population, UK, 2016-2018

    For prostate cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

    The age distribution of prostate cancer cases probably partly reflects the age groups in which prostate specific antigen testing and transurethral resection of the prostate are carried out.

    Recommendations For Future Research

    Prostate Cancer Incidence: Early Dose Of A Unique Micronutrient Mix Shows Greater Reduction.

    According to the results of this study, estimating the survival rate of prostate cancer requires more extensive studies at the level of other Asian countries, especially in the West and Central Asia, as most studies in this study were conducted in South and Southeast of Asia, and estimates are somewhat incorrect. Another suggestion could be a study of the survival of prostate cancer in patients who metastasized, which was not our study goal, and is an important issue in clinical decision making and the continuation of treatment.

    Recommended Reading: Prostate Cancer Erectile Dysfunction Treatment

    Cancer Incidence And Mortality Patterns By The 4

    Incidence rates increased with increasing HDI level, ranging from 104.3 and 128.0 per 100,000 in low HDI countries to 335.3 and 267.6 per 100,000 in very high HDI countries for men and women, respectively . Mortality rates are about 2-fold higher in higher HDI countries versus lower HDI countries in men, whereas little variation exists across HDI levels in women .

    • a Incidence excludes basal cell carcinoma, whereas mortality includes all types of nonmelanoma skin cancer.
    • Abbreviation: HDI, Human Development Index.

    Figures and show cancer incidence and mortality ASRs in higher HDI versus lower HDI countries for men and women, respectively, in 2020. For incidence in men , lung cancer ranks first and prostate cancer ranks second in higher HDI countries, and vice versa for lower HDI countries . These cancers were followed by colorectal cancer in higher HDI countries, largely reflecting the substantial contribution by the United States, and lip and oral cavity cancer in lower HDI countries because of the high burden of the disease in India. In women , incidence rates for breast cancer far exceed those of other cancers in both transitioned and transitioning countries, followed by colorectal cancer in transitioned countries and cervical cancer in transitioning countries.

    Figure 7

    Reducing The Cancer Burden

    Between 30 and 50% of cancers can currently be prevented by avoiding risk factors and implementing existing evidence-based prevention strategies. The cancer burden can also be reduced through early detection of cancer and appropriate treatment and care of patients who develop cancer. Many cancers have a high chance of cure if diagnosed early and treated appropriately.

    You May Like: Procedure To Clean Out Prostate

    Inclusion And Exclusion Criteria

    All observational studies stated the survival rate of localized prostate cancer in Asian countries were included in the study. Articles of other cancers reported survival in people who reported regional, metastatic, as well as review and meta-analysis studies were excluded. It should be noted that studies that did not report the sample size or confidence interval of survival rates were not included in the meta-analysis.

    Cancer Incidence And Death Rates By Sex And World Region

    Worldwide Prostate Cancer Epidemiology: Differences ...

    Worldwide, the incidence rate for all cancers combined was 19% higher in men than in women in 2020, although rates varied widely across regions. Among men, incidence rates ranged almost 5-fold, from 494.2 per 100,000 in Australia/New Zealand to 100.6 per 100,000 in Western Africa among women, rates varied nearly 4-fold, from 405.2 per 100,000 in Australia/New Zealand to 102.5 per 100,000 in South Central Asia. These variations largely reflect differences in exposure to risk factors and associated cancers and barriers to high-quality cancer prevention and early detection. For example, the highest overall incidence rates in Australia/New Zealand are caused in part by an elevated risk of NMSC because most of the population is light-skinned, and excessive sun exposure is prevalent, in conjunction with increased detection of the disease.

    The gender gap for overall cancer mortality worldwide is twice that for incidence, with death rates 43% higher in men than in women , partly because of differences in the distribution of the cancer types. Death rates per 100,000 persons varied from 165.6 per 100,000 in Eastern Europe to 70.2 per 100,000 in Central America among men and from 118.3 per 100,000 in Melanesia to 63.1 per 100,000 in Central America and South Central Asia among women. Notably, the cumulative risk of dying from cancer among women in 2020 was higher in Eastern Africa than in Northern America , Western Europe , and Australia/New Zealand .

    CANCER SITE

    Lung cancer

    Recommended Reading: How To Self Examine For Prostate Cancer

    Survival Rate Of Prostate Cancer In Each Country

    Overall, the results of the survival of prostate cancer in nine countries and three other areas has been showed in the Table 2. The highest survival rates of one, five, and ten-years were reported in Japan , Korea , and Japan , respectively, and the lowest survival rates for these years were observed in China , Philippines , and China , respectively.

    Table 2

    Result of meta-analysis and heterogeneity of survival rate of prostate cancer in Asia based on each country and years of survival.

    Country

    * NR: Not reported.

    Awareness And Early Detection In Africa

    Based on the review and analysis of published studies and data, PCa incidence in Africa has been documented to be lower than that of African American men. PCa incidence rates in African men have increased between 1987 and 1992 and continue to increase over time . According to , no data exists on the prevalence of PSA testing in Africa, but it is generally held that early detection testing is not common. Given that PSA testing is relatively rare in several African countries such as Nigeria and The Gambia, PCa incidence rates are projected to increase as early detection, clinical diagnosis protocols, and economies improve. It is likely that improved availability and access to medical care and systems as well as better attainment, reporting, and documentation of cases may contribute to an increasing incidence rate trend .

    Don’t Miss: Psa Levels And Prostate Cancer

    Deaths From Prostate Cancer

    Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About 1 man in 41 will die of prostate cancer.

    Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.1 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.

    Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

    American Cancer Society. Facts & Figures 2021. American Cancer Society. Atlanta, Ga. 2021.

    National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed at https://seer.cancer.gov/statfacts/html/prost.html on March 15, 2019.

    Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA . SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

    American Cancer Society. Facts & Figures 2021. American Cancer Society. Atlanta, Ga. 2021.

    National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed at https://seer.cancer.gov/statfacts/html/prost.html on March 15, 2019.

    Last Revised: January 12, 2021

    Global Incidence Of Prostate Cancer In Developing And Developed Countries With Changing Age Structures

    Prostate cancer incidence and urinary incontinence after prostate surgery
    • Jeremy Y. C. Teoh,

      Roles Conceptualization, Data curation, Methodology

      Affiliation S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    • Hoyee W. Hirai,

      Roles Data curation, Formal analysis

      Affiliation Stanley Ho Big Data Decision Analytics Research Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    • Jason M. W. Ho,

      Roles Data curation, Formal analysis, Methodology

      Affiliations Stanley Ho Big Data Decision Analytics Research Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    • Felix C. H. Chan,

      Roles Data curation, Formal analysis

      Affiliation Stanley Ho Big Data Decision Analytics Research Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    Recommended Reading: Stage Four Prostate Cancer Prognosis

    Prostate Cancer Incidence And Mortality Have Declined In Most Countries

    Date:
    American Association for Cancer Research
    Summary:
    Prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world, with the United States recording the biggest drop in incidence, according to new results.

    Prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world, with the United States recording the biggest drop in incidence, according to results presented at the AACR Annual Meeting 2019, March 29-April 3.

    Despite the trend toward declining or stabilizing rates, prostate cancer remains the second most commonly diagnosed cancer and the sixth leading cause of cancer death among men worldwide, said the study’s lead author, MaryBeth Freeman, MPH, senior associate scientist, Surveillance Research, at the American Cancer Society in Atlanta.

    “Previous studies have indicated significant variation in prostate cancer rates, due to factors including detection practices, availability of treatment, and genetic factors,” Freeman said. “By comparing rates from different countries, we can assess differences in detection practices and improvements in treatment.”

    Of the 44 countries examined for incidence data, prostate cancer rates during the most recent five-year period increased in four countries, with Bulgaria showing the largest increase. Rates decreased in seven countries, with the United States showing the largest decrease. Rates stabilized in the remaining 33 countries.

    Story Source:

    Treatment Of Prostate Cancer

    The treatments that someone who has to undergo for prostate cancer varies depending on how severe the cancer is and how much it has progressed. If diagnosed early enough then a doctor may just recommend active surveillance in which regular blood tests, rectal exams, and even biopsies may be performed to monitor the disease. If the cancer is progressing then other, more extreme treatment option are taken. These can include external beam radiation therapy, brachytherapy , various hormone therapies, cryosurgery , chemotherapy and biological therapy. Depending on what stage a person’s prostate cancer is at and what a person’s doctor recommends will decide what treatment or treatments are done.

    Don’t Miss: Where Does Prostate Cancer Commonly Metastasize To

    RELATED ARTICLES

    Most Popular